A. Zuiable
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
-
- Cancer Treatment and Pharmacology
Papers in
- Hematology 10
- Multiple Myeloma Research and Treatments 5
- Platelet Disorders and Treatments 4
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 3
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- S Milan (2 shared papers)Martin Gore (4 shared papers)U. M. Hegde (3 shared papers)Simon Ball (3 shared papers)T J McElwain (2 shared papers)B. C. Millar (2 shared papers)Jo Bell (1 shared paper)Peter Clark (1 shared paper)
- Journals
- British Journal of Haematology (5 papers)Cancer Chemotherapy and Pharmacology (1 paper)Hematological Oncology (1 paper)The Lancet (1 paper)Clinical & Laboratory Haematology (3 papers)
- Partner nations
- United KingdomUnited States
In The Last Decade
A. Zuiable
13 papers receiving 333 citations
Peers
Comparison fields: 5 of 43
- Hematology 310
- Oncology 121
- Genetics 46
- Immunology 38
- Public Health, Environmental and Occupational Health 43
Countries citing papers authored by A. Zuiable
This map shows the geographic impact of A. Zuiable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Zuiable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Zuiable more than expected).
Fields of papers citing papers by A. Zuiable
This network shows the impact of papers produced by A. Zuiable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Zuiable. The network helps show where A. Zuiable may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Zuiable, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 157 | |
| 2 | Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. | 1988 | 57 |
| 3 | 1985 | 33 | |
| 4 | 1989 | 28 | |
| 5 | 1985 | 14 | |
| 6 | 1989 | 14 | |
| 7 | 1985 | 12 | |
| 8 | 2008 | 8 | |
| 9 | The use of melphalan in conjunction with total body irradiation as treatment for acute leukaemia. | 1989 | 7 |
| 10 | 1990 | 6 | |
| 11 | 1985 | 6 | |
| 12 | 1988 | 5 | |
| 13 | 1987 | 1 |
About A. Zuiable
A. Zuiable is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 13 papers that have together received 348 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Platelet Disorders and Treatments (4 papers), Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Autoimmune Bullous Skin Diseases (2 papers), Cancer therapeutics and mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Hematology (310 citations), Oncology (121 citations), Genetics (46 citations), Immunology (38 citations) and Public Health, Environmental and Occupational Health (43 citations). A. Zuiable has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include S Milan, Martin Gore, U. M. Hegde, Simon Ball, T J McElwain, B. C. Millar, Jo Bell, Peter Clark, J. S. Malpas and Peter J. Selby. Their work appears in journals such as British Journal of Haematology, Cancer Chemotherapy and Pharmacology, Hematological Oncology, The Lancet and Clinical & Laboratory Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.